Irvine, Calif — SoundCure has formally received $3 million in funding to help launch the commercialization of a novel sound-based tinnitus therapy first developed at the University of California at Irvine (UCI). Allied Minds Inc led the financing.
SoundCure’s tinnitus therapy pioneered by Dr Fan-Gang Zeng at UCI with research funded by the American Tinnitus Association (ATA) has reportedly shown great success in bringing relief to sufferers of tinnitus.
The SoundCure technology utilizes unique tones and sounds customized to an individual’s own tinnitus to help quiet the ringing. The proprietary SoundCure audio stimuli are designed to be presented at a softer level than the patient’s tinnitus to lower the patient’s overall sound burden and reduce or eliminate the perception of tinnitus.
The company says that the new funds will be used for an aggressive commercialization plan that brings with it a new medical device capable of delivering the suite of SoundCure’s tinnitus therapies and directly addressing tinnitus in an approach to quiet and control the symptoms of tinnitus.
The company also intends to partner with audiologists, MDs and patient advocacy groups and leverage innovative Web-based technologies to treat patients and provide tinnitus solutions.
SOURCE: Allied Minds
